Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomasAna Guerreiro Stücklin, Nataliya Zhukova, Anthony Arnoldo et al.|Nature Communications|2019Cited by 372
Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic targetMarianne Hütt-Cabezas, Fausto J. Rodríguez, Matthias A. Karajannis et al.|Neuro-Oncology|2013Cited by 80
High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activitySohyon Lee, Berend Snijder, Tobias Weiß et al.|Nature Medicine|2024Cited by 68
Targeting tumour-intrinsic neural vulnerabilities of glioblastomaSohyon Lee, Berend Snijder, Tobias Weiß et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 3